These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1723202)

  • 1. [Plasma renin activity in women with hyperthyroidism].
    Zdrojewicz Z
    Pol Arch Med Wewn; 1991 Aug; 86(2):101-6. PubMed ID: 1723202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of angiotensin-converting enzyme in women with hyperthyroidism accompanying Graves-Basedow disease].
    Zdrojewicz Z
    Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1004-5. PubMed ID: 1339053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regulation of aldosterone secretion in thyrotoxicosis. Thyroid hormones as possible stimulators of the activity of the renin-angiotensin-aldosterone system].
    Rom-Bugoslavskaia ES; Komarova IV
    Probl Endokrinol (Mosk); 1986; 32(2):13-6. PubMed ID: 2424003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of poststimulatory plasma renin activity in women with hyperthyroidism or hypothyroidism in relation to therapy.
    Marcisz C; Kucharz EJ; Marcisz-Orzel M; Poręba R; Orzel A; Sioma-Markowska U
    Neuro Endocrinol Lett; 2011; 32(3):301-7. PubMed ID: 21712789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyrostatic drug therapy of Basedow disease. Combination with thyroid hormones and/or beta blockers].
    Weissel M
    Acta Med Austriaca; 1987; 14(3-4):74-6. PubMed ID: 2447739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma atrial natriuretic peptide, plasma renin activity and aldosterone during treatment of hyperthyroidism due to Graves' disease.
    Shigematsu S; Iwasaki T; Aizawa T; Ishihara M; Shinoda T; Yamada T; Sato A; Takemura Y
    Horm Metab Res; 1989 Sep; 21(9):514-8. PubMed ID: 2531114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of antioxidative enzymes and concentration of malondialdehyde as oxidative status markers in women with newly diagnosed Graves-Basedow disease and after thiamazole therapy leading to euthyroidism.
    Rybus-Kalinowska B; Zwirska-Korczala K; Kalinowski M; Kukla M; Birkner E; Jochem J
    Pol Arch Med Wewn; 2008; 118(7-8):420-5. PubMed ID: 18714737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dynamics of PBI behavior in blood serum of patients with Graves-Basedow disease and toxic nodular goiter during treatment with methimetazole].
    Jaruga-Dolińska E; Zembrzuska Z; Korman E
    Endokrynol Pol; 1971; 22(6):535-43. PubMed ID: 4110630
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thyrostatic agents are not always indicated. Treatment errors in overactive thyroid gland].
    MMW Fortschr Med; 2004 Apr; 146(14):46. PubMed ID: 15344759
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma inactive renin in patients with hyperthyroidism.
    Nakamaru M; Ogihara T; Higaki J; Kumahara Y; Murakami K; Kuma K
    J Clin Endocrinol Metab; 1983 Jan; 56(1):198-201. PubMed ID: 6183289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of Basedow-Graves disease in pregnancy].
    Konrády A
    Orv Hetil; 1995 Dec; 136(50):2721-5. PubMed ID: 8532325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum IL-18 levels are not increased in patients with untreated Graves' ophthalmopathy.
    Wakelkamp IM; Prummel MF; Wiersinga WM
    Horm Metab Res; 2004 Jan; 36(1):44-7. PubMed ID: 14983406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contemporary views on treatment with thyrostatic drugs for hyperthyroidism associated with Graves' disease].
    Syrenicz A; Czekalski S
    Endokrynol Pol; 1991; 42(4):603-12. PubMed ID: 1285390
    [No Abstract]   [Full Text] [Related]  

  • 17. [The course of diffuse hyperthyroidism in Basedow disease].
    Schifferdecker E
    Fortschr Med; 1990 Jan; 108(1):42-4. PubMed ID: 1690164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Graves-Basedow disease, factors that influence in their relapse].
    Martí Cabané J
    An Med Interna; 2003 Jul; 20(7):388. PubMed ID: 12951976
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperthyroidism in Graves' disease--antithyroid drug treatment].
    Schumm-Draeger PM
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():41-5. PubMed ID: 10355049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical evolution of a cohort of patients with Graves-Basedow disease treated with metimazole].
    De Luis DA; Arconada A; Aller R; Cuéllar LA; Terroba MC; Martín Gil J
    Med Clin (Barc); 2002 Jun; 118(20):777-8. PubMed ID: 12049693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.